News
Latest News
Controlled substances
6 May 2022
Update to list of controlled substances
Business Plan: January - June 2022
9 March 2022
The Office of Drug Control Business Plan for 2022 is now available.
Appointment of Members for the Third Tenure of the Australian Advisory Council on the Medicinal Use of Cannabis (the Council)
16 February 2022
The Third Tenure of the Australian Advisory Council on the Medicinal Use of Cannabis (the Council).
Medicinal cannabis single licence and permit reforms
24 December 2021
Medicinal Cannabis Single Licence and Permit reforms commencing 24 December 2021
Cost Recovery Implementation Statement (CRIS) - Regulation of Medicinal Cannabis 2021-22
21 December 2021
Provides information on how the Office of Drug Control implements cost recovery for regulatory activities.
ODC Suspends Licences of Medicinal Cannabis Licence Holder
1 December 2021
Office of Drug Control suspends cultivation and manufacture licences of Queensland Medicinal Cannabis Licence Holder
Testing of cannabis, cannabis resin and products manufactured from cannabis and cannabis resin
26 August 2021
Guidance note for 'Testing of cannabis and cannabis resin' updated.
Enactment of the Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021
7 July 2021
The Amendment Act provides for amendments to the Narcotic Drugs Act 1967 to support an innovative Australian medicinal cannabis industry for the benefit of Australian patients.
Australian Government response to the Senate Community Affairs References Committee report: Inquiry into Current barriers to patient access to medicinal cannabis in Australia
4 March 2021
The Australian Government response to the Inquiry into current barriers to patient access to medicinal cannabis has now been published
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
4 February 2021
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021